We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Idorsia Ltd | LSE:0RQE | London | Ordinary Share | CH0363463438 | IDORSIA N ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.9775 | 1.879 | 2.076 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 827,958 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/12/2024 | 06:00 | UKREG | Idorsia provides update on the exclusive negotiations for the global rights.. |
| 27/11/2024 | 06:00 | UKREG | Idorsia enters into exclusive negotiations for global rights to.. |
| 11/11/2024 | 16:45 | UKREG | Idorsia is advancing the treatment of hypertension with new data at the.. |
| 29/10/2024 | 06:00 | UKREG | Idorsia announces financial results for the first nine months of 2024 |
| 16/10/2024 | 05:00 | UKREG | New data on aprocitentan to be presented at the ASN Kidney Week 2024 |
| 17/9/2024 | 15:45 | UKREG | Idorsia continues to further the science of sleep and insomnia with new.. |
| 05/9/2024 | 15:45 | UKREG | New data on aprocitentan to be presented at the AHA Hypertension Scientific.. |
| 02/9/2024 | 15:45 | UKREG | Amended terms of Idorsia’s 2024 convertible bonds become effective |
| 25/7/2024 | 05:00 | UKREG | Idorsia announces financial results for the first half 2024 |
| 18/7/2024 | 15:45 | UKREG | Invitation to Idorsia's Half Year 2024 Financial Reporting webcast and.. |
1 Year Idorsia Chart |
Intraday Idorsia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
